Fidelity Disruptive Medicine ETF (FMED) Dividend Yield, History & Forecast

Fidelity Disruptive Medicine ETF (FMED) is an exchange-traded fund (ETF) listed on the NASDAQ Global Market. The most recent ex-dividend date was December 20, 2024, with payment scheduled for December 24, 2024. market capitalization is approximately $74M.

Loading quote...

FMED fund composition

FMED holds 63 positions, with 33.6% of assets in its ten largest. It charges an expense ratio of 0.50%, and manages $52.3M.

Top 10 holdings

HoldingWeight
NTRANATERA INC4.40%
TXG10X GENOMICS INC4.32%
TMOTHERMO FISHER SCIENTIFIC INC4.23%
DHRDANAHER CORP3.96%
ILMNILLUMINA INC3.04%
LFSTLIFESTANCE HEALTH GROUP INC2.91%
DIM.PASARTORIUS STEDIM BIOTECH2.84%
ARGXARGENX SE SPONSORED ADR2.71%
RVMDREVOLUTION MEDICINES INC2.61%
MRNAMODERNA INC2.57%

Sector allocation

Health Care98.9%Healthcare95.8%Cash & Others2.3%Technology1.8%Financial Services1.4%

Frequently Asked Questions about Fidelity Disruptive Medicine ETF (FMED)

When does Fidelity Disruptive Medicine ETF pay its next dividend?
The most recent ex-dividend date was December 20, 2024. The next scheduled dividend payment date is December 24, 2024.
Is Fidelity Disruptive Medicine ETF a Dividend Aristocrat?
Dividend Aristocrat status requires an S&P 500 listing and 25 or more consecutive years of dividend increases. See our curated Dividend Aristocrats list for the full roster.
What sector is Fidelity Disruptive Medicine ETF in?
Fidelity Disruptive Medicine ETF (FMED) operates in the Financial Services sector, specifically the Asset Management industry.